Close to 200 stockbrokers have closed their doors in Hong Kong since 2020, and industry players expect more to throw…
Read More »Guangzhou Innogen Pharmaceutical Group
Nearly half of the biotech and technology start-ups seeking initial public offerings (IPOs) in Hong Kong are opting for confidential…
Read More »Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals…
Read More »Hong Kong stocks posted the first back-to-back decline in two weeks on Friday after China’s July economic data fell short…
Read More »


